DJIA 17,093.82 14.25 0.08%
NASDAQ 4,576.40 18.71 0.41%
S&P 500 2,001.67 4.93 0.25%
market minute promo


company name or ticker

Progenics Pharmaceuticals (PGNX) Q1 2014 Results - Earnings Call Webcast

Earnings Scheduled For May 9, 2014

Progenics Finishes Patient Enrollment - Analyst Blog

Progenics Pharmaceuticals Announces Completion of Enrollment of Chemotherapy Naive Cohort in Phase I

Progenics Pharmaceuticals Announces Completion of Enrollment of Chemotherapy Naive Cohort in Phase II Trial of PSMA ADC

US Stock Futures Edge Higher Ahead Of McDonald's Earnings

Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the Acceptance of Submission to Expand Use

Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the Acceptance of Submission to Expand Use of RELISTORby the European Medicines Agency

Progenics Pharmaceuticals (PGNX): An Off-the-Radar Potential Winner - Tale of the Tape

Progenics Q4 Loss Narrower Than Expected - Analyst Blog

Progenics Pharmaceuticals' CEO Discusses Q4 2013 Results - Earnings Call Transcript

Sector Update: Health Care

See More Articles...